GBP1
GBP1 (guanylate binding protein 1) is an interferon-inducible GTPase that contributes to innate immunity against bacterial, viral and protozoan pathogens. It hydrolyses GTP to GDP and then to GMP, and promotes both inflammasome assembly and autophagy after infection. Browse Assay Genie's current range of GBP1 research reagents below, or read on for the biology behind the target.
GBP1 is a GTPase whose expression is induced by interferon. It hydrolyses GTP to GMP in two consecutive cleavage reactions, converting GTP first to GDP and then to GMP in a processive manner. After infection, GBP1 is recruited to pathogen-containing vacuoles or to bacteria that have escaped them. There it promotes inflammasome assembly and autophagy, and it helps lyse the vacuoles so that pathogens are released into the cytosol.
Once pathogens are in the cytosol, GBP1 forms a GTPase-dependent protein coat around them. This coat promotes detection of pathogen ligands by pattern recognition receptors. For Gram-negative bacteria, the coat binds lipopolysaccharide directly. This disrupts the O-antigen barrier and unmasks lipid A, which the non-canonical inflammasome effector CASP4/CASP11 then detects. GBP1 also promotes recruitment of proteins that mediate bacterial cytolysis. The resulting release of double-stranded DNA activates the AIM2 inflammasome. In autophagy, GBP1 interacts with SQSTM1 to regulate the generation of bacteriolytic peptides. Reported protective roles include defence against L. monocytogenes, M. bovis BCG and T. gondii, and antiviral activity against influenza virus.
The GBP1 gene belongs to the guanylate binding protein group. The protein falls in the GB1 subfamily of the GB1/RHD3 GTPase family, within the dynamin-like GTPase superfamily. Guanylate binding proteins bind the guanine nucleotides GMP, GDP and GTP. They are distinguished from other GTP-binding proteins by having two binding motifs rather than three. The protein has been localised to cytoplasmic vesicle and Golgi membranes, the cell membrane and the cytosol, and it is also annotated as secreted. Earlier gene names described it as an interferon-inducible, 67kDa guanylate binding protein, and the mouse ortholog is Gbp1.
GBP1 is an interferon-inducible GTPase with roles in innate defence against diverse bacterial, viral and protozoan pathogens.
GBP1 promotes inflammasome assembly, including detection of LPS by CASP4/CASP11 and AIM2 activation through released double-stranded DNA.
GBP1 interacts with SQSTM1 to regulate generation of bacteriolytic peptides, linking the GTPase to autophagy-based pathogen control.
GBP1 confers protection against L. monocytogenes, M. bovis BCG and T. gondii, and shows antiviral activity against influenza virus.
GBP1 is an interferon-inducible GTPase that hydrolyses GTP to GDP and then GMP. After infection it is recruited to pathogen-containing vacuoles or to escaped bacteria. There it promotes inflammasome assembly and autophagy, and it forms a protein coat that aids detection of pathogen ligands.
The HGNC name is guanylate binding protein 1, and no alternative symbols are listed. Earlier names described it as interferon-inducible, 67kDa. It belongs to the guanylate binding proteins and to the GB1 subfamily of the dynamin-like GTPase superfamily.
A mouse ortholog, Gbp1, is recorded for the human GBP1 gene. UniProt describes protective roles against several pathogens, including L. monocytogenes, M. bovis BCG and T. gondii. Check the datasheet of any product for its validated reactivity.
Other guanylate binding proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P32455; product specifications from Assay Genie datasheets.